Back to top
Deczuba 50 mg Injection
Deczuba 50 mg Injection

Deczuba 50 mg Injection

Deczuba 50 mg Injection Specification

  • Salt Composition
  • Decitabine 50 mg
  • Pacakaging (Quantity Per Box)
  • 1 vial per box
  • Origin of Medicine
  • Synthetic
  • Drug Type
  • Injection
  • Ingredients
  • Decitabine
  • Physical Form
  • Liquid
  • Function
  • Treatment of certain types of blood cancers such as Myelodysplastic syndromes (MDS) and Acute Myeloid Leukemia (AML)
  • Recommended For
  • Patients diagnosed with Myelodysplastic syndromes (MDS) or Acute Myeloid Leukemia (AML)
  • Dosage
  • 50 mg per vial
  • Dosage Guidelines
  • Administered under medical supervision through intravenous infusion typically once a day for a 5-day cycle; dosage and duration depend on physician recommendation and patient condition
  • Suitable For
  • Adults
  • Quantity
  • 1 vial
  • Storage Instructions
  • Store at 2C to 8C (Refrigeration); protect from light and keep out of reach of children
 
 

About Deczuba 50 mg Injection



Deczuba 50 mg Injection is a potent medication containing Decitabine, designed to treat Myelodysplastic syndromes (MDS) and Acute Myeloid Leukemia (AML) in adults. Administered intravenously once daily for a 5-day cycle, the dosage and duration are determined by the physician based on the patients condition. Each vial contains 50 mg of Decitabine in liquid form. This synthetic drug is stored refrigerated at 2C to 8C, shielded from light, and kept away from children. With each box containing 1 vial, this injection offers effective therapy for certain blood cancers, helping patients combat these diseases effectively.

FAQs of Deczuba 50 mg Injection:


Q: Who is Deczuba 50 mg Injection suitable for?

A: Deczuba 50 mg Injection is suitable for adults.

Q: What is the recommended dosage for Deczuba 50 mg Injection?

A: The recommended dosage is 50 mg per vial, administered intravenously under medical supervision once daily for a 5-day cycle.

Q: What conditions is Deczuba 50 mg Injection recommended for?

A: It is recommended for patients diagnosed with Myelodysplastic syndromes (MDS) and Acute Myeloid Leukemia (AML).

Q: How should Deczuba 50 mg Injection be stored?

A: Deczuba 50 mg Injection should be stored at 2C to 8C, refrigerated, protected from light, and kept out of reach of children.

Q: What is the function of Deczuba 50 mg Injection?

A: Deczuba 50 mg Injection is used for the treatment of certain types of blood cancers such as Myelodysplastic syndromes (MDS) and Acute Myeloid Leukemia (AML).

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti-Cancer Category

Herclon 440 mg Injection

Herclon 440 mg Injection

Physical Form : Liquid Injection, Other

Origin of Medicine : Biological

Ingredients : Trastuzumab

Function : Other, Treatment of HER2positive breast cancer

Pacakaging (Quantity Per Box) : 1 vial per box

Salt Composition : Trastuzumab (440 mg)

Adrisome 20 mg Injection

Adrisome 20 mg Injection

Physical Form : Liquid

Origin of Medicine : Allopathic

Ingredients : Adriamycin (Doxorubicin hydrochloride)

Function : Used to treat various types of cancer by inhibiting DNA replication in cancerous cells., Other

Pacakaging (Quantity Per Box) : 1 vial per box

Salt Composition : Doxorubicin hydrochloride

Celcarb 150 mg Injection

Celcarb 150 mg Injection

Physical Form : Liquid

Origin of Medicine : Synthetic

Ingredients : Carboplatin

Function : Other, Used to treat various types of cancer

Pacakaging (Quantity Per Box) : 1 vial per box

Salt Composition : Carboplatin

Sutykine 12.5 mg Capsule

Sutykine 12.5 mg Capsule

Physical Form : Other, Capsule

Origin of Medicine : Synthetic

Ingredients : Synthetic compounds

Function : Other, Treat certain medical conditions

Pacakaging (Quantity Per Box) : Varies standard packaging information can be confirmed

Salt Composition : 12.5 mg specific active ingredient (details typically on packaging)